Cellular Biology |
From the Department of Cardiology (L.W., G.O., M.G., D.E.), Transfusion Medicine (M.L.O.), and Cell and Molecular Biology (M.D.W.), Lund University Hospital, Lund, Sweden.
Correspondence to Dr David Erlinge, Department of Cardiology, Lund University Hospital, S-221 85 Lund, Sweden. E-mail david.erlinge{at}kard.lu.se
Red blood cells may regulate tissue circulation and O2 delivery by releasing the vasodilator ATP in response to hypoxia. When released extracellularly, ATP is rapidly degraded to ADP in the circulation by ectonucleotidases. In this study, we show that ADP acting on P2Y13 receptors on red blood cells serves as a negative feedback pathway for the inhibition of ATP release. mRNA of the ADP receptor P2Y13 was highly expressed in human red blood cells and reticulocytes. The stable ADP analogue 2-MeSADP decreased ATP release from red blood cells by inhibition of cAMP. The P2Y12 and P2Y13 receptor antagonist AR-C67085 (30 µmol/L), but not the P2Y1 blocker MRS2179, inhibited the effects of 2-MeSADP. At doses where AR-C67085 only blocks P2Y12 (100 nmol/L), it had no effect. AR-C67085 and the nucleotidase apyrase increased cAMP per se, indicating a constant cAMP inhibitory effect of endogenous extracellular ADP. 2-MeSADP reduced plasma ATP concentrations in an in vivo pig model. Our results indicate that the ATP degradation product ADP inhibits ATP release by acting on the red blood cell P2Y13 receptor. This negative feedback system could be important in the control of plasma ATP levels and tissue circulation.
Key Words: ATP release cAMP P2 receptors microdialysis red blood cells
This article has been cited by other articles:
![]() |
R. Sluyter, A. N. Shemon, W. E. Hughes, R. O. Stevenson, J. G. Georgiou, G. D. Eslick, R. M. Taylor, and J. S. Wiley Canine erythrocytes express the P2X7 receptor: greatly increased function compared with human erythrocytes Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2007; 293(5): R2090 - R2098. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. G. Yegutkin, S. S. Samburski, S. P. Mortensen, S. Jalkanen, and J. Gonzalez-Alonso Intravascular ADP and soluble nucleotidases contribute to acute prothrombotic state during vigorous exercise in humans J. Physiol., March 1, 2007; 579(2): 553 - 564. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. B. Arthur, S. Georgi, K. Akassoglou, and P. A. Insel Inhibition of apoptosis by P2Y2 receptor activation: novel pathways for neuronal survival. J. Neurosci., April 5, 2006; 26(14): 3798 - 3804. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Heptinstall, J. R. Glenn, A. Johnson, B. Myers, A. E. White, and L. Zhao Leukocytosis, Vascular Disease, and Adenine Nucleotide Metabolism Arterioscler. Thromb. Vasc. Biol., February 1, 2006; 26(2): e22 - e23. [Full Text] [PDF] |
||||
![]() |
D. Ferrari, A. la Sala, E. Panther, J. Norgauer, F. Di Virgilio, and M. Idzko Activation of human eosinophils via P2 receptors: novel findings and future perspectives J. Leukoc. Biol., January 1, 2006; 79(1): 7 - 15. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2005 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |